Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Debt to Equity (2017 - 2018)

Autolus Therapeutics' Debt to Equity history spans 2 years, with the latest figure at $0.0 for Q4 2018.

  • For Q4 2018, Debt to Equity changed N/A year-over-year to $0.0; the TTM value through Dec 2018 reached $0.0, changed N/A, while the annual FY2018 figure was $0.0, 72.2% down from the prior year.
  • Debt to Equity reached $0.0 in Q4 2018 per AUTL's latest filing, down from $0.0 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.01 in Q3 2017 to a low of $0.0 in Q4 2018.